KHẢO SÁT ẢNH HƯỞNG CỦA TUỔI, BỆNH TĂNG HUYẾT ÁP,  ĐÁI THÁO ĐƯỜNG LÊN NGUY CƠ CHUYỂN NẶNG  Ở BỆNH NHÂN COVID – 19

Đăng Ninh Trần; Văn Tám Lê; Phước Phương Lê; Văn Khanh Đặng; Thị Trà My Đặng

doi:10.59354/ydth175.2022.29

Keywords:

SARS-CoV 2

Abstract

Background: The global outbreak of highly contagious coronavirus 2019 has led medical system of nations, psychological, and socio – economic conditions to a challenging situation that they never thought before. Covid -19 portrays probably one of greatest threats in this century that the countries have to tackle. Therefore, scientists are trying to understand the pathogenesis, clinical implications, and develop novel preventive strategies.

Objective: to evaluate the impact of age, comorbidities on the severity of Covid – 19.

Methods: retrospective cross – sectional study.

Result: presence of at least one comorbidity hypertension, diabetes individually increased the severity of Covid - 19 cases significantly (OR: 12, p = 0,000, (95%CI: 4,2 – 35,5)). Cases at the age of ≥ 50 years (OR = 4,9, p = 0,002 (95%CI: 1,78 – 13,46) were severely affected by SARS – CoV -2.

Conclusions: older patients (age ≥ 50 years) are at higher risk of developing severity, whereas comorbidities could significantly affect the severity of Covid -19

References

Nguyễn Gia Bình, Lương Ngọc Khuê, Nguyễn Văn Kính, Ngô Quý Châu, Trần Hữu Dàng., et al. (2021). Hướng dẫn chẩn đoán và điều trị COVID-19, Bộ Y tế.

Barek, M. A., Aziz, M. A., & Islam, M. S. (2020). Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A metaanalysis with 55 studies and 10014 cases. Heliyon, 6(12), e05684.

Islam, M. S., Barek, M. A., Aziz, M. A., Aka, T. D., et al. (2020). Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a metaanalysis with 85 studies and 67299 cases. medRxiv.

Liang, W., Liang, H., Ou, L., Chen, B., et al. (2020). Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA internal medicine, 180(8), 1081- 1089.

Singh, A. K., Singh, A., Shaikh, A., Singh, R., et al. (2020). Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(3), 241-246.